Evidence map›Paper›PMID 36296350›Full record

ArticleMicroorganisms2022

Trends in Asymptomatic Nasopharyngeal

Julie-Anne Lemay, Leah J Ricketson, James D Kellner

Abstract read
In one paragraph

Article in Microorganisms, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Julie-Anne LemayDepartment of Pediatrics, University of Calgary, Calgary, AB T2N 1N4, Canada.
Leah J RicketsonDepartment of Pediatrics, University of Calgary, Calgary, AB T2N 1N4, Canada.ORCID 0000-0003-1369-8391
James D KellnerDepartment of Pediatrics, University of Calgary, Calgary, AB T2N 1N4, Canada.ORCID 0000-0002-9083-2980

Funding

Pfizer (Canada) W1222857
6 · The paper itself

Abstract

We previously reported trends in pneumococcal nasopharyngeal carriage in the post-PCV13 era as detected by conventional culture methods. Our current aim is to assess if there are fundamental differences in the clinical and demographic features of children who have pneumococcal carriage detected by qPCR compared with culture analysis. The CASPER team conducted point-prevalence surveys in 2016 in healthy children in Calgary to determine trends in overall and serotype-specific pneumococcal nasopharyngeal carriage. Being 18 months of age (

Indexed as

13-valent pneumococcal conjugate vaccinenasopharyngeal carriageStreptococcus pneumoniae

Identifiers

PMID36296350
PMCPMC9607440

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.